Amgen Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Needham Starts NeoVolta (NEOV) at Buy
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
Amgen (AMGN) Tops Q2 EPS by 38c, Offers FY Guidance
July 30, 2019 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $3.97, $0.38 better than the analyst estimate of $3.59. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.68 billion.
GUIDANCE:
Amgen sees FY2019 EPS of $13.75-$14.30, versus the consensus of $13.97. Amgen sees... More
